(Q34396689)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24405366%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Current concepts and progress in RSV vaccine development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24405366%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24405366%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Aleks K Guvenel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24405366%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Christopher Chiu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24405366%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

9 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24405366%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24405366%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24405366%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24405366%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

333-344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24405366%20AND%20SRC:MED&resulttype=core&format=json

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Protective and dysregulated T cell immunity in RSV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus and recurrent wheeze in healthy preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Immune responses and disease enhancement during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Innate cells and T helper 2 cell immunity in airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Animal models of human respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Viral load drives disease in humans experimentally infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Activation of the granzyme pathway in children with severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Bovine respiratory syncytial virus: infection dynamics within and between herds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Vaccine-Induced Immunopathology during Bovine Respiratory Syncytial Virus Infection: Exploring the Parameters of Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

The cotton rat model of respiratory viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Primary respiratory syncytial virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Effectiveness of maternal influenza immunization in mothers and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030ΔSH) at permissive and non-permissive temperatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Advances in and the potential of vaccines for respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus: current progress in vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Virus-like particles: passport to immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

Adenoviruses as vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.878653

10.1586/14760584.2014.878653

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24405366%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference